Cargando…
Statin Use as a Moderator of Metformin Effect on Risk for Prostate Cancer Among Type 2 Diabetic Patients
OBJECTIVE: Metformin and statins have shown promise for cancer prevention. This study assessed whether the effect of metformin on prostate cancer (PCa) incidence varied by statin use among type 2 diabetic patients. RESEARCH DESIGN AND METHODS: The study cohort consisted of 5,042 type 2 diabetic male...
Autores principales: | Lehman, Donna M., Lorenzo, Carlos, Hernandez, Javier, Wang, Chen-pin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3329836/ https://www.ncbi.nlm.nih.gov/pubmed/22456867 http://dx.doi.org/10.2337/dc11-1829 |
Ejemplares similares
-
Individual and joint effects of metformin and statins on mortality among patients with high‐risk prostate cancer
por: Tan, Xiang‐Lin, et al.
Publicado: (2020) -
Population-wide impacts of aspirin, statins, and metformin use on prostate cancer incidence and mortality
por: Koo, Hye Yeon, et al.
Publicado: (2021) -
Metformin and statin use associate with plasma protein N-glycosylation in people with type 2 diabetes
por: Singh, Sunny S, et al.
Publicado: (2020) -
Associations of aspirin, statins and metformin with lung cancer risk and related mortality
por: Frille, Armin, et al.
Publicado: (2021) -
Impact of metformin on statin‐associated myopathy risks in dyslipidemia patients
por: Bak, Keunhyeong, et al.
Publicado: (2023)